Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LEARNING TECHNOLOGIES GROUP PLC Director's Dealing 2020

May 1, 2020

7759_dirs_2020-05-01_80eaa5e9-0dfc-46c8-b2d1-18b89698244a.html

Director's Dealing

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

National Storage Mechanism | Additional information

RNS Number : 6907L

Learning Technologies Group PLC

01 May 2020

1 May 2020

Learning Technologies Group plc

(AIM: LTG)

Director dealing

Learning Technologies Group plc, provider of services and technologies for digital learning and talent management, announces that on 30 April 2020 Leslie-Ann Reed (Non-executive Director) sold 1,300,000 Ordinary Shares in the Company at an average price of 125.0 pence per Ordinary Share.  The purpose of this sale and of the sale of shares announced on 24 April 2020 are to fund a house purchase.

Following the transaction above, Leslie-Ann Reed's beneficial holding in the Company is 4,839,463 Ordinary Shares and this holding represents approximately 0.721 per cent of the Company's issued share capital.

Enquiries:

Learning Technologies Group plc

Jonathan Satchell, Chief Executive

Neil Elton, Chief Financial Officer
+44 (0)20 7402 1554
Numis Securities Limited (NOMAD and Joint Corporate Broker)

Stuart Skinner, Nick Westlake, Ben Stoop
+44 (0)20 7260 1000
Goldman Sachs International (Joint Corporate Broker)

Bertie Whitehead, Adam Laikin
+44 (0)20 7774 1000
FTI Consulting (Public Relations Adviser)

Rob Mindell, Jamie Ricketts, Chris Birt
+44 (0)20 3727 1000

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

DSHBBGDUBUGDGGB